Skip to main content

Eledon Pharmaceuticals, Inc.

ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001404281

No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q3 2026, worth $115.1M in total; no superinvestor holds it.

Holders of 5% or more of ELDN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Eledon Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ELDN
HolderLatest formStakeChangeFirst filedLatest filingFiling
Biotechnology Value Fund L P13G/A9.99%8.66M shares0.00 ppfrom 9.99%Feb 16, 20219 filingsNov 16, 2026SEC
BlackRock, Inc.13G5.80%4.38M shares+1.20 ppfrom 4.60%Jul 17, 20253 filingsApr 27, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

39 Schedule 13D and 13G filings on Eledon Pharmaceuticals, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ELDN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 16, 20264:10 PM ETBiotechnology Value Fund L Pand 9 others13G/A9.99%8.66M shares0.00 ppfrom 9.99%Sep 30, 2026SEC
Oct 30, 202611:25 AM ETVanguard Capital Management LLC13G/A4.87%3.96M shares−0.18 ppfrom 5.05%Below 5%Sep 30, 2026SEC
Jul 31, 202610:17 AM ETVanguard Capital Management LLC13G5.05%3.90M sharesNewJun 30, 2026SEC
May 15, 20264:07 PM ETBiotechnology Value Fund L Pand 9 others13G/A9.99%7.87M shares–Mar 31, 2026SEC
Apr 27, 20264:12 PM ETBlackRock, Inc.13G5.80%4.38M shares+1.20 ppfrom 4.60%Mar 31, 2026SEC
Mar 26, 20266:03 PM ETVanguard Group Inc13G/A0.00%0 shares−5.54 ppfrom 5.54%Below 5%Mar 13, 2026SEC
Feb 17, 20264:27 PM ETRa Capital Management, L.P.and 3 others13G/A0.00%0 shares–Below 5%Dec 31, 2025SEC
Feb 13, 20264:15 PM ETCoastlands Capital LPand 4 others13G/A4.99%3.94M shares−0.99 ppfrom 5.98%Below 5%Dec 31, 2025SEC
Jan 21, 202612:30 PM ETBlackRock, Inc.13G/A4.60%3.63M shares−0.80 ppfrom 5.40%Below 5%Dec 31, 2025SEC
Nov 24, 20253:28 PM ETCoastlands Capital LPand 4 others13G5.98%4.76M sharesNewNov 19, 2025SEC
Jul 29, 20251:13 PM ETVanguard Group Inc13G5.54%3.32M sharesNewJun 30, 2025SEC
Jul 17, 20257:54 PM ETBlackRock, Inc.13G5.40%3.25M sharesNewJun 30, 2025SEC
Feb 14, 20255:34 PM ETArmistice Capital, LLCand 1 other13G/A4.99%3.14M shares–Below 5%Dec 31, 2024SEC
Feb 14, 202511:22 AM ETFrazier Life Sciences Public Fund, L.P.and 16 others13G/A2.00%1.18M shares–Below 5%Dec 31, 2024SEC
Nov 14, 2024Armistice Capital, LLC13G/AOld format–––SEC
Nov 5, 2024Frazier Life Sciences Public Fund, L.P.13GOld format–New–SEC
Nov 5, 2024Ra Capital Management, L.P.13GOld format–New–SEC
Oct 31, 2024Biotechnology Value Fund L P13G/AOld format–––SEC
Oct 31, 2024Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 14, 2024Armistice Capital, LLC13GOld format–New–SEC
Feb 14, 2024Cormorant Asset Management, LP13G/AOld format–––SEC
Feb 14, 2024Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 14, 2023Cormorant Asset Management, LP13G/AOld format–––SEC
Feb 14, 2022Cormorant Asset Management, LP13G/AOld format–––SEC
Feb 11, 2022Woodline Partners LP13G/AOld format–––SEC
Feb 10, 2022Adage Capital Partners GP, L.L.C.13G/AOld format–––SEC
Feb 9, 2022FMR LLC13G/AOld format–––SEC
Jan 28, 2022Biotechnology Value Fund L P13G/AOld format–––SEC
Jan 26, 2022Logos Global Management LP13G/AOld format–––SEC
Jan 11, 2022Biotechnology Value Fund L P13G/AOld format–––SEC
Jan 11, 2022Biotechnology Value Fund L P13G/AOld format–––SEC
Sep 9, 2021Logos Global Management LP13G/AOld format–––SEC
Feb 16, 2021Woodline Partners LP13GOld format–New–SEC
Feb 16, 2021683 Capital Management, LLC13G/AOld format–––SEC
Feb 16, 2021Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 8, 2021FMR LLC13GOld format–New–SEC
Jan 5, 2021OrbiMed Israel BioFund GP Limited Partnership13D/AOld format–––SEC
Jan 4, 2021Cormorant Asset Management, LP13GOld format–New–SEC
Jan 4, 2021Adage Capital Partners GP, L.L.C.13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Eledon Pharmaceuticals, Inc. shares.

No Form 144 notices for Eledon Pharmaceuticals, Inc. are on file.